Semi-Annual Consolidated Statement Of Cash Flows

Medrx Co.,Ltd. - Filing #7722215

Concept 2018-01-01 to
2018-06-30
As at
2018-06-30
As at
2017-12-31
As at
2017-06-30
2017-01-01 to
2017-06-30
As at
2016-12-31
Semi-annual consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss) before income taxes
-570,784,000 JPY
-475,382,000 JPY
Depreciation
18,430,000 JPY
28,292,000 JPY
Interest and dividend income
-462,000 JPY
-227,000 JPY
Foreign exchange losses (gains)
2,109,000 JPY
JPY
Share of loss (profit) of entities accounted for using equity method
JPY
758,000 JPY
Decrease (increase) in trade receivables
-8,666,000 JPY
-86,000 JPY
Decrease (increase) in inventories
1,360,000 JPY
6,081,000 JPY
Increase (decrease) in trade payables
2,113,000 JPY
-108,000 JPY
Other, net
476,000 JPY
-8,300,000 JPY
Subtotal
-582,473,000 JPY
-459,918,000 JPY
Interest and dividends received
462,000 JPY
227,000 JPY
Income taxes paid
-4,176,000 JPY
-4,720,000 JPY
Net cash provided by (used in) operating activities
-568,177,000 JPY
-422,854,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-2,310,000 JPY
-39,608,000 JPY
Net cash provided by (used in) investing activities
608,689,000 JPY
-39,608,000 JPY
Cash flows from financing activities
Net cash provided by (used in) financing activities
1,365,763,000 JPY
JPY
Effect of exchange rate change on cash and cash equivalents
-3,559,000 JPY
2,446,000 JPY
Net increase (decrease) in cash and cash equivalents
1,402,716,000 JPY
-460,017,000 JPY
Cash and cash equivalents
2,529,510,000 JPY
1,126,794,000 JPY
2,179,919,000 JPY
2,639,936,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.